Literature DB >> 19184239

Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.

Barbara Shih1, Jason J Brown, Daniel J Armstrong, Tommy Lindau, Ardeshir Bayat.   

Abstract

Dupuytren's disease (DD) is a benign fibroproliferative tumor with an unknown etiology and high recurrence postsurgery. Several observations suggest the possible involvement of skin overlying nodule (SON) and the subcutaneous fat in the pathogenesis of DD. This study aims to (1) compare the gene expression levels of SON and subcutaneous fat in DD and normal subjects and (2) to compare transverse palmar fascia (Skoog's fibers) from DD patients as internal control tissue, with palmar fascia (transverse carpal ligament) from patients undergoing carpal tunnel release as external control. Skin, fat, and fascia were obtained from five DD patients of Caucasian origin (age = 66 +/- 14) and from five control subjects (age = 57 +/- 19) undergoing carpal tunnel release. Total ribonucleic acids was extracted from each sample and used for complementary deoxyribonucleic acid synthesis. Real-time quantitative polymerase chain reaction was used to assess the gene expression levels of six candidate genes: A disintegrin and metalloproteinase domain (ADAM12), aldehyde dehydrogenase 1 family member A1 (ALDH1A1), iroquois homeoboxprotein 6 (IRX6), periostin, osteoblast specific factor, proteoglycan 4, and tenascin C. Using independent t test, ADAM12, ALDH1A1, and IRX6 expression levels in DD fats were significantly (p < 0.05) higher than those in the controls. There is no significant difference in the gene expression levels of all six genes when comparing disease and control fascia and skin. Interestingly, ADAM12 up-regulation has also been observed in several other fibrotic and proliferative disorders. In conclusion, this study demonstrates potential roles for subcutaneous fat in DD pathogenesis as well as supports the use of transverse palmar fascia as appropriate control tissues in DD research.

Entities:  

Year:  2009        PMID: 19184239      PMCID: PMC2724615          DOI: 10.1007/s11552-009-9164-0

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  45 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family.

Authors:  F Z Hu; A Nystrom; A Ahmed; M Palmquist; R Dopico; I Mossberg; J Gladitz; M Rayner; J C Post; G D Ehrlich; R A Preston
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

Review 3.  The polymerase chain reaction and its application to clinical plastic surgery.

Authors:  S Rea; S T O'Sullivan
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006       Impact factor: 2.740

Review 4.  Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Clin Pract Urol       Date:  2005-06

5.  Dermofasciectomy and proximal interphalangeal joint replacement in Dupuytren's disease.

Authors:  M A Tonkin; W P Lennon
Journal:  J Hand Surg Br       Date:  1985-10

6.  Gene and cluster-specific expression of the Iroquois family members during mouse development.

Authors:  A C Houweling; R Dildrop; T Peters; J Mummenhoff; A F Moorman; U Rüther; V M Christoffels
Journal:  Mech Dev       Date:  2001-09       Impact factor: 1.882

7.  Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.

Authors:  K Iba; R Albrechtsen; B J Gilpin; F Loechel; U M Wewer
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

8.  The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

Authors:  Stacy Carl-McGrath; Uwe Lendeckel; Matthias Ebert; Albert Roessner; Christoph Röcken
Journal:  Int J Oncol       Date:  2005-01       Impact factor: 5.650

9.  Dupuytren's contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients.

Authors:  M A Tonkin; F D Burke; J P Varian
Journal:  J Hand Surg Br       Date:  1984-06

10.  Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.

Authors:  Barbara Shih; Dulharie Wijeratne; Daniel J Armstrong; Tommy Lindau; Philip Day; Ardeshir Bayat
Journal:  J Hand Surg Am       Date:  2009-01       Impact factor: 2.230

View more
  11 in total

1.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

2.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

Review 3.  Periostin as a multifunctional modulator of the wound healing response.

Authors:  John T Walker; Karrington McLeod; Shawna Kim; Simon J Conway; Douglas W Hamilton
Journal:  Cell Tissue Res       Date:  2016-05-28       Impact factor: 5.249

4.  Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells.

Authors:  Lei Cai; Robert H Brophy; Eric D Tycksen; Xin Duan; Ryan M Nunley; Muhammad Farooq Rai
Journal:  FASEB J       Date:  2019-04-16       Impact factor: 5.191

Review 5.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

6.  Identification of novel keloid biomarkers through profiling of tissue biopsies versus cell cultures in keloid margin specimens compared to adjacent normal skin.

Authors:  Barbara Shih; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Eplasty       Date:  2010-04-07

7.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

8.  Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.

Authors:  Heather E Wheeler; Anna González-Neira; Guillermo Pita; Julio-Cesar de la Torre-Montero; Rosario Alonso; Luis A Lopez-Fernandez; Emilio Alba; Miguel Martín; M Eileen Dolan
Journal:  Pharmacogenet Genomics       Date:  2014-05       Impact factor: 2.089

9.  Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity.

Authors:  Benjamin S Misemer; Amy P N Skubitz; J Carlos Manivel; Stephen C Schmechel; Edward Y Cheng; Jonathan C Henriksen; Joseph S Koopmeiners; Christopher L Corless; Keith M Skubitz
Journal:  Cancer Med       Date:  2013-11-26       Impact factor: 4.452

Review 10.  Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.

Authors:  Franz Rödel; Claudia Fournier; Julia Wiedemann; Felicitas Merz; Udo S Gaipl; Benjamin Frey; Ludwig Keilholz; M Heinrich Seegenschmiedt; Claus Rödel; Stephanie Hehlgans
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.